| Followers | 82 |
| Posts | 21657 |
| Boards Moderated | 2 |
| Alias Born | 04/16/2019 |
Wednesday, July 30, 2025 8:59:01 AM
Gotcha
I got some - go get em!!!!!!!!!!!
I got some - go get em!!!!!!!!!!!
Recent PFSA News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 09:30:22 PM
- Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform • GlobeNewswire Inc. • 04/06/2026 10:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/04/2026 05:15:14 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/02/2026 02:10:43 PM
- Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering • GlobeNewswire Inc. • 02/27/2026 02:15:00 PM
- Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/13/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/12/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:47 PM
- Profusa Announces 1-for-75 Reverse Stock Split • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 01/29/2026 01:00:00 PM
- Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue • GlobeNewswire Inc. • 01/16/2026 12:30:00 PM
- Profusa Adds Leading Greek Vascular Surgeon to Customer Base • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Profusa Bolsters European Commercial Network with New French Distributor, MedSell • GlobeNewswire Inc. • 12/31/2025 12:30:00 PM
- Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 12/11/2025 01:30:00 PM
- Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 11/24/2025 01:15:00 PM
- Profusa Announces Third Quarter Business and Financial Highlights • GlobeNewswire Inc. • 11/19/2025 10:44:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:19:05 PM
- Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches • GlobeNewswire Inc. • 10/30/2025 11:30:00 AM
- Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 • GlobeNewswire Inc. • 10/28/2025 12:30:00 PM
- Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe • GlobeNewswire Inc. • 10/22/2025 12:30:00 PM
- Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe • GlobeNewswire Inc. • 10/15/2025 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/09/2025 09:20:04 PM
